HCPCS code J3403 — Revakinagene, per implant. Status: Active. Effective Oct 1, 2025. Source: CMS HCPCS Level II.

J3403

Active

Revakinagene, per implant

Revakinagene taroretcel-lwey, per implant

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Oct 1, 2025
Code type: alphanumeric
OPPS Status: G — Pass-through drugs and biologicals
OPPS APC: 0897

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2025-Q4
    Revakinagene, per implant